Amicus Therapeutics (0HF9.LSE) Q4 2023 Earnings

Feb 28Confirmed
Q4 2023
-0.11
-0.09
-0.08
-0.06

Details

Expected EPS
-0.05782
Actual EPS
-0.11
Surprise EPS
-0.05
Surprise Percent
-90.25%

Description

⁨Amicus Therapeutics⁩ (⁦0HF9.LSE⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts